Moleculin Biotech, Inc.

SEC 4 · Filed

0001437749-26-037745Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Nov 17, 2026

Grant, award or other acquisition by George Robert E.

Security
Stock Options (right to buy)
Code
A
Shares
4,000
Price per share
Unreported
Structured facts
{
  "code": "A",
  "date": "2026-11-17",
  "direction": "A",
  "exercise_price": "6.83",
  "expiration": "2036-11-17",
  "footnotes": {
    "F1": "The options set forth in this table vest on the earlier of November 17, 2027 or the date of the Company\u0027s next annual meeting of shareholders, subject to the grantee\u0027s continued service on the Company\u0027s Board of Directors on the vesting date.",
    "F2": "The options were issued in connection with the reporting person\u0027s Board of Director service to the Company."
  },
  "owners": [
    {
      "cik": "0001674701",
      "name": "George Robert E.",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "4334",
  "price": null,
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Options (right to buy)",
  "shares": "4000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "4000"
}